ERA-话题@MedSci

#ERA#

425篇内容 | 3180人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1738826, encodeId=cf991e388268c, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=FDA批准第一个Strattera仿制药，治疗多动症, objectType=article, longId=100426, objectId=f39f10042628, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f39f10042628, replyNumber=0, likeNumber=60, createdTime=2017-11-03, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f39f10042628, moduleTitle=FDA批准第一个Strattera仿制药，治疗多动症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f39f10042628)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738820, encodeId=25531e3882008, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=开发T细胞疗法&nbsp武田或将$1亿收购Gammadelta&nbspTherapeutics, objectType=article, longId=98383, objectId=f6769838393, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6769838393, replyNumber=0, likeNumber=57, createdTime=2017-12-13, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6769838393, moduleTitle=开发T细胞疗法&nbsp武田或将$1亿收购Gammadelta&nbspTherapeutics, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6769838393)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738830, encodeId=4e841e3883016, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Pharmacotherapy：现有干预措施对自闭症谱系障碍儿童的睡眠问题是否有效？, objectType=article, longId=103975, objectId=e3dc1039e5d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3dc1039e5d2, replyNumber=0, likeNumber=62, createdTime=2017-08-13, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3dc1039e5d2, moduleTitle=Pharmacotherapy：现有干预措施对自闭症谱系障碍儿童的睡眠问题是否有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3dc1039e5d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738869, encodeId=79561e3886996, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Advanced Accelerator Applications 旗下LUTATHERA获批用于胃肠胰神经内分泌肿瘤治疗, objectType=article, longId=128054, objectId=039a12805491, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=039a12805491, replyNumber=0, likeNumber=78, createdTime=2019-01-01, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=039a12805491, moduleTitle=Advanced Accelerator Applications 旗下LUTATHERA获批用于胃肠胰神经内分泌肿瘤治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=039a12805491)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738837, encodeId=1a9f1e388377e, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Theranostics :小分子化合物YD277通过激活内质网应激抑制三阴性乳腺癌, objectType=article, longId=108314, objectId=544310831440, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=544310831440, replyNumber=0, likeNumber=74, createdTime=2017-09-25, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=544310831440, moduleTitle=Theranostics :小分子化合物YD277通过激活内质网应激抑制三阴性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=544310831440)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738858, encodeId=86651e3885881, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Cytotherapy：缺氧诱导因子1A通过miR-675-5P来调节hMSC的血管成骨作用, objectType=article, longId=122102, objectId=6dff12210238, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6dff12210238, replyNumber=0, likeNumber=53, createdTime=2018-04-21, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6dff12210238, moduleTitle=Cytotherapy：缺氧诱导因子1A通过miR-675-5P来调节hMSC的血管成骨作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6dff12210238)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738824, encodeId=69f61e388244d, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Pharmacotherapy：慢性阻塞性肺病：LABA/LAMA还是LABA/ICS？, objectType=article, longId=99192, objectId=5d76991927f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d76991927f, replyNumber=0, likeNumber=73, createdTime=2017-12-22, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d76991927f, moduleTitle=Pharmacotherapy：慢性阻塞性肺病：LABA/LAMA还是LABA/ICS？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d76991927f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738816, encodeId=68c41e3881695, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Pharmacotherapy：万古霉素联合PTZ延长vs标准输注相关肾毒性发生率, objectType=article, longId=96604, objectId=37df9660425, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37df9660425, replyNumber=0, likeNumber=73, createdTime=2017-06-22, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37df9660425, moduleTitle=Pharmacotherapy：万古霉素联合PTZ延长vs标准输注相关肾毒性发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37df9660425)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738809, encodeId=d3991e3880925, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Lancet：HERA 研究 11 年随访：曲妥珠单抗可提高 Her2 阳性乳腺癌生存, objectType=article, longId=92706, objectId=edf692e06e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edf692e06e3, replyNumber=0, likeNumber=74, createdTime=2017-11-30, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edf692e06e3, moduleTitle=Lancet：HERA 研究 11 年随访：曲妥珠单抗可提高 Her2 阳性乳腺癌生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edf692e06e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738860, encodeId=24771e388602f, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Theranostics：细胞外膜泡在心血管疾病诊断与治疗中的作用, objectType=article, longId=123467, objectId=dcbf12346e8c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcbf12346e8c, replyNumber=0, likeNumber=62, createdTime=2018-08-07, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcbf12346e8c, moduleTitle=Theranostics：细胞外膜泡在心血管疾病诊断与治疗中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcbf12346e8c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738828, encodeId=d7fd1e38828fc, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Betalin Therapeutics被评为年度更佳生物科技初创企业, objectType=article, longId=101600, objectId=5f1e1016006d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f1e1016006d, replyNumber=0, likeNumber=69, createdTime=2018-04-14, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f1e1016006d, moduleTitle=Betalin Therapeutics被评为年度更佳生物科技初创企业, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f1e1016006d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738822, encodeId=d2161e38822c3, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Aliment Pharm Therap：哪种静脉铁制剂治疗炎性肠病患者缺铁性贫血更具有效性和耐受性？, objectType=article, longId=98524, objectId=b609985241c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b609985241c, replyNumber=0, likeNumber=83, createdTime=2018-04-10, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b609985241c, moduleTitle=Aliment Pharm Therap：哪种静脉铁制剂治疗炎性肠病患者缺铁性贫血更具有效性和耐受性？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b609985241c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738840, encodeId=0cd61e38840d1, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Theranostics：金纳米粒子的大小可影响人牙周膜祖细胞的成骨分化, objectType=article, longId=109104, objectId=540510910474, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=540510910474, replyNumber=0, likeNumber=55, createdTime=2017-12-23, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=540510910474, moduleTitle=Theranostics：金纳米粒子的大小可影响人牙周膜祖细胞的成骨分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=540510910474)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738811, encodeId=bf891e3881132, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Aliment Pharm Therap：粪便菌群移植治疗复发性CDI-新鲜、冷冻还是冻干菌群？, objectType=article, longId=94756, objectId=09d594e5610, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09d594e5610, replyNumber=0, likeNumber=55, createdTime=2017-06-10, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09d594e5610, moduleTitle=Aliment Pharm Therap：粪便菌群移植治疗复发性CDI-新鲜、冷冻还是冻干菌群？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09d594e5610)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738863, encodeId=ae671e3886308, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=堪比乐视找到融创？Theranos获一亿美元“救命钱”, objectType=article, longId=124648, objectId=df3512464878, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df3512464878, replyNumber=0, likeNumber=76, createdTime=2018-04-17, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df3512464878, moduleTitle=堪比乐视找到融创？Theranos获一亿美元“救命钱”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df3512464878)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738850, encodeId=a8d91e3885047, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=勃林格殷格翰携手MiNA Therapeutics公司共同研发肝纤维化疾病新型治疗手段, objectType=article, longId=120149, objectId=7e731201496a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e731201496a, replyNumber=0, likeNumber=57, createdTime=2018-10-19, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e731201496a, moduleTitle=勃林格殷格翰携手MiNA Therapeutics公司共同研发肝纤维化疾病新型治疗手段, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e731201496a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738808, encodeId=2d0e1e388087b, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Mol Therapy：以瘤之盾，治瘤之矛：新研究开发出更安全有效的CAR T疗法！, objectType=article, longId=87992, objectId=83598e99253, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83598e99253, replyNumber=0, likeNumber=56, createdTime=2017-08-21, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83598e99253, moduleTitle=Mol Therapy：以瘤之盾，治瘤之矛：新研究开发出更安全有效的CAR T疗法！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83598e99253)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738848, encodeId=3a591e38848fc, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Aliment Pharm Therap:他汀常规使用与降低酒精性肝硬化患者死亡率相关, objectType=article, longId=116832, objectId=0d5e11683250, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d5e11683250, replyNumber=0, likeNumber=96, createdTime=2017-12-20, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d5e11683250, moduleTitle=Aliment Pharm Therap:他汀常规使用与降低酒精性肝硬化患者死亡率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d5e11683250)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738832, encodeId=a4a61e38832ed, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Pharmacotherapy：低剂量纳络酮能否预防术后恶心和呕吐, objectType=article, longId=103979, objectId=c63f1039e92b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c63f1039e92b, replyNumber=0, likeNumber=83, createdTime=2017-12-24, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c63f1039e92b, moduleTitle=Pharmacotherapy：低剂量纳络酮能否预防术后恶心和呕吐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c63f1039e92b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738806, encodeId=26141e388064d, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=路在何方？Theranos再次宣布裁员41%, objectType=article, longId=87410, objectId=21a18e41016, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21a18e41016, replyNumber=0, likeNumber=58, createdTime=2017-04-12, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21a18e41016, moduleTitle=路在何方？Theranos再次宣布裁员41%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21a18e41016)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ERA

2020-05-29

一叶知秋 (审核中...)

前往app查看评论内容

#ERA#

FDA批准第一个Strattera仿制药，治疗多动症

2017-11-03

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

开发T细胞疗法&nbsp武田或将$1亿收购Gammadelta&nbspTherapeutics

2017-12-13

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Pharmacotherapy：现有干预措施对自闭症谱系障碍儿童的睡眠问题是否有效？

2017-08-13

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Advanced Accelerator Applications 旗下LUTATHERA获批用于胃肠胰神经内分泌肿瘤治疗

2019-01-01

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Theranostics :小分子化合物YD277通过激活内质网应激抑制三阴性乳腺癌

2017-09-25

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Cytotherapy：缺氧诱导因子1A通过miR-675-5P来调节hMSC的血管成骨作用

2018-04-21

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Pharmacotherapy：慢性阻塞性肺病：LABA/LAMA还是LABA/ICS？

2017-12-22

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Pharmacotherapy：万古霉素联合PTZ延长vs标准输注相关肾毒性发生率

2017-06-22

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Lancet：HERA 研究 11 年随访：曲妥珠单抗可提高 Her2 阳性乳腺癌生存

2017-11-30

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Theranostics：细胞外膜泡在心血管疾病诊断与治疗中的作用

2018-08-07

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Betalin Therapeutics被评为年度更佳生物科技初创企业

2018-04-14

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Aliment Pharm Therap：哪种静脉铁制剂治疗炎性肠病患者缺铁性贫血更具有效性和耐受性？

2018-04-10

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Theranostics：金纳米粒子的大小可影响人牙周膜祖细胞的成骨分化

2017-12-23

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Aliment Pharm Therap：粪便菌群移植治疗复发性CDI-新鲜、冷冻还是冻干菌群？

2017-06-10

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

堪比乐视找到融创？Theranos获一亿美元“救命钱”

2018-04-17

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

勃林格殷格翰携手MiNA Therapeutics公司共同研发肝纤维化疾病新型治疗手段

2018-10-19

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Mol Therapy：以瘤之盾，治瘤之矛：新研究开发出更安全有效的CAR T疗法！

2017-08-21

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Aliment Pharm Therap:他汀常规使用与降低酒精性肝硬化患者死亡率相关

2017-12-20

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Pharmacotherapy：低剂量纳络酮能否预防术后恶心和呕吐

2017-12-24

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

路在何方？Theranos再次宣布裁员41%

2017-04-12

科室
- - 订阅+
  - 更多科室
工具
服务